Comparison of 5-FU vs capecitabine in combination with mitomycin or cisplatin in the treatment of anal cancer.

被引：0
|
作者：
Yu, Irene
Cheung, Winson Y.
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.3576
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3576
引用
收藏
页数：5
相关论文
共 50 条
  • [11] COST MINIMIZATION ANALYSIS OF ADVANCED GASTRIC CANCER TREATMENT WITH CAPECITABINE/CISPLATIN (XP) VS. 5-FU/CISPLATIN (FP) REGIMENS IN POLISH SETTING
    Kawalec, P.
    Szawlowski, A.
    Federowicz, I
    Szkultecka-Debek, M.
    Russel-Szymczyk, M.
    VALUE IN HEALTH, 2008, 11 (06) : A473 - A473
  • [12] Economic assessment of capecitabine/cisplatin versus 5-FU/cisplatin regimens in adjuvant treatment of advanced gastric cancer in Spain
    Safont, M.
    Darba, J.
    Restovic, G.
    Sastre, J.
    Bellmunt Molins, J.
    Gomez, M. A.
    Salgado, M.
    Vila, C.
    Ramirez De Arellano, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [13] Can capecitabine replace 5-FU/leucovorin in combination with oxaliplatin for the treatment of advanced colorectal cancer?
    Twelves, C
    ONCOLOGY-NEW YORK, 2002, 16 (12): : 23 - 26
  • [14] ECONOMIC ASSESSMENT OF CAPECITABINE/CISPLATIN VERSUS 5-FU/CISPLATIN REGIMENS IN ADJUVANT TREATMENT OF ADVANCED GASTRIC CANCER IN SPAIN
    Darba, J.
    Restovic, G.
    Ramirez de Arellano, A.
    Safont, M.
    Sastre, J.
    Bellmunt, J.
    Gomez, M.
    Salgado, M.
    Vila, C.
    ANNALS OF ONCOLOGY, 2008, 19 : 184 - 184
  • [15] COMPARISON OF TREATMENT OF METASTATIC GASTROINTESTINAL CANCER WITH 5-FLUOROURACIL (5-FU) TO A COMBINATION OF 5-FU WITH CYTOSINE-ARABINOSIDE
    GAILANI, S
    HOLLAND, JF
    BURNINGHAM, R
    LEONE, L
    LARSEN, V
    FALKSON, G
    CANCER, 1972, 29 (05) : 1308 - +
  • [16] Pharmacokinetics of cisplatin and combination chemotherapy of cisplatin plus 5-FU
    Saijo, N
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1998, 28 (03) : 157 - 157
  • [17] CISPLATIN, DOXORUBICIN, AND 5-FU IN COMBINATION FOR ADVANCED GASTRIC-CANCER
    VOGL, SE
    ENGSTROM, PF
    CANCER TREATMENT REPORTS, 1984, 68 (10): : 1273 - 1275
  • [18] Activity of genacitabine/5-FU combination in refractory esophagogastrie (EG) cancer.
    Won, Elizabeth
    Ilson, David H.
    Chou, Joanne F.
    Capanu, Marinela
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [19] Activity of gemcitabine/5-FU combination in refractory esophagogastric (EG) cancer.
    Won, Elizabeth
    Ilson, David H.
    Chou, Joanne F.
    Capanu, Marinela
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [20] COST MINIMIZATION ANALYSIS (CMA) OF CAPECITABINE/CISPLATIN (XP) VS. 5-FU/CISPLATIN (FP) REGIMENS IN ADVANCED GASTRIC CANCER (AGC) TREATMENT IN THE ROMANIAN SETTING
    Curescu, S.
    Stanculeanu, D. L.
    Croitoru, A.
    Radu, C. P.
    VALUE IN HEALTH, 2011, 14 (07) : A453 - A453
12345